Estimated plasma volume status in heart failure: clinical implications and future directions.
Congestion
Heart failure
Hematocrit
Hemoglobin
Plasma volume
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
14
10
2020
accepted:
10
12
2020
pubmed:
8
1
2021
medline:
30
12
2021
entrez:
7
1
2021
Statut:
ppublish
Résumé
Congestion is one of the main predictors of poor outcome in patients with heart failure (HF). Assessing and monitoring congestion is essential for optimizing HF therapy. Among the various available methods, serial measurements of estimated plasma volume (ePVS) using routine blood count and/or body weight (e.g., the Strauss, Duarte, Hakim formulas) may be useful in HF management. Further prospective study is warranted to determine whether ePVS can help optimize decongestion therapy (loop diuretics, mineralocorticoid receptor antagonists, SGLT2i) in various HF settings. This narrative review summarizes the recent evidence supporting the association of ePVS with clinical congestion and outcome(s) and discusses future directions for monitoring ePVS in HF.
Identifiants
pubmed: 33409701
doi: 10.1007/s00392-020-01794-8
pii: 10.1007/s00392-020-01794-8
doi:
Substances chimiques
Biomarkers
0
Cardiovascular Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1159-1172Informations de copyright
© 2021. Springer-Verlag GmbH, DE part of Springer Nature.
Références
Rubio-Gracia J, Demissei BG, Ter Maaten JM, Cleland JG, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, Damman K, Perez-Calvo JI, Voors AA (2018) Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol 258:185–191
pubmed: 29544928
doi: 10.1016/j.ijcard.2018.01.067
pmcid: 29544928
Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Fillieux L, Abraham WT, Januzzi J Jr, Sebbag L, Zannad F, Mebazaa A, Rossignol P (2018) Ini-Crct GN and the EFHFG Integrative assessment of congestion in heart failure throughout the patient journey. JACC Heart Fail 6:273–285
pubmed: 29226815
doi: 10.1016/j.jchf.2017.09.023
Yancy CW, Jessup M, Bozkurt B, Masoudi FA, Butler J, McBride PE, Casey DE Jr, McMurray JJ, Drazner MH, Mitchell JE, Fonarow GC, Peterson PN, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol 62:e147–e239
pubmed: 23747642
doi: 10.1016/j.jacc.2013.05.019
Miller WL (2016) Fluid volume overload and congestion in heart failure: time to reconsider pathophysiology and how volume is assessed. Circ Heart Fail 9:e002922
pubmed: 27436837
doi: 10.1161/CIRCHEARTFAILURE.115.002922
Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure, A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 82:1724–1729
pubmed: 2146040
doi: 10.1161/01.CIR.82.5.1724
Kalra PR, Anagnostopoulos C, Bolger AP, Coats AJS, Anker SD (2002) The regulation and measurement of plasma volume in heart failure. J Am Coll Cardiol 39:1901–1908
pubmed: 12084586
doi: 10.1016/S0735-1097(02)01903-4
Nijst P, Verbrugge FH, Bertrand PB, Martens P, Dupont M, Drieskens O, Penders J, Tang WH, Mullens W (2017) Plasma volume is normal but heterogeneously distributed, and true anemia is highly prevalent in patients with stable heart failure. J Card Fail 23:138–144
pubmed: 27561853
doi: 10.1016/j.cardfail.2016.08.008
Kaplan E, Puestow RC, Baker LA, Kruger S (1954) Blood volume in congestive heart failure as determined with iodinated human serum albumin. Am Heart J 47:824–838
pubmed: 13158266
doi: 10.1016/0002-8703(54)90154-4
Fudim M, Hernandez AF, Felker GM (2017) Role of volume redistribution in the congestion of heart failure. J Am Heart Assoc 6:e006817
pubmed: 28862947
pmcid: 5586477
doi: 10.1161/JAHA.117.006817
Miller WL, Mullan BP (2014) Understanding the heterogeneity in volume overload and fluid distribution in decompensated heart failure is key to optimal volume management: role for blood volume quantitation. JACC Heart Fail 2:298–305
pubmed: 24952698
doi: 10.1016/j.jchf.2014.02.007
Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P (2001) Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 38:963–968
pubmed: 11583865
doi: 10.1016/S0735-1097(01)01479-6
Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122:265–272
pubmed: 20606118
pmcid: 3025294
doi: 10.1161/CIRCULATIONAHA.109.933275
Greene SJ, Gheorghiade M, Vaduganathan M, Ambrosy AP, Mentz RJ, Subacius H, Maggioni AP, Nodari S, Konstam MA, Butler J, Filippatos G, and investigators ET (2013) Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail 15:1401–1411
pubmed: 23845795
pmcid: 4199468
doi: 10.1093/eurjhf/hft110
van der Meer P, Postmus D, Ponikowski P, Cleland JG, O’Connor CM, Cotter G, Metra M, Davison BA, Givertz MM, Mansoor GA, Teerlink JR, Massie BM, Hillege HL, Voors AA (2013) The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol 61:1973–1981
pubmed: 23500313
doi: 10.1016/j.jacc.2012.12.050
Pellicori P, Shah P, Cuthbert J, Urbinati A, Zhang J, Kallvikbacka-Bennett A, Clark AL, Cleland JGF (2019) Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure. Eur J Heart Fail 21:904–916
pubmed: 30666769
doi: 10.1002/ejhf.1383
Montero D, Lundby C, Ruschitzka F, Flammer AJ (2017) True anemia-red blood cell volume deficit-in heart failure: a systematic review. Circ Heart Fail 10(5):e003610
pubmed: 28455293
doi: 10.1161/CIRCHEARTFAILURE.116.003610
Androne AS, Hryniewicz K, Hudaihed A, Mancini D, Lamanca J, Katz SD (2004) Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 93:1254–1259
pubmed: 15135699
doi: 10.1016/j.amjcard.2004.01.070
Strobeck JE, Feldschuh J, Miller WL (2018) Heart failure outcomes with volume-guided management. JACC Heart Fail 6:940–948
pubmed: 30316941
doi: 10.1016/j.jchf.2018.06.017
Strauss MB, Davis RK, Rosenbaum JD, Rossmeisl EC (1951) Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution. J Clin Invest 30:862–868
pubmed: 14861307
pmcid: 436321
doi: 10.1172/JCI102501
Dill DB, Costill DL (1974) Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 37:247–248
pubmed: 4850854
doi: 10.1152/jappl.1974.37.2.247
Buffaloe GW, Heineken FG (1983) Plasma volume nomograms for use in therapeutic plasma exchange. Transfusion 23:355–357
pubmed: 6879681
doi: 10.1046/j.1537-2995.1983.23483276879.x
Sprenger KB, Huber K, Kratz W, Henze E (1987) Nomograms for the prediction of patient’s plasma volume in plasma exchange therapy from height, weight, and hematocrit. J Clin Apher 3:185–190
pubmed: 3558344
doi: 10.1002/jca.2920030313
Duarte K, Monnez JM, Albuisson E, Pitt B, Zannad F, Rossignol P (2015) Prognostic Value of Estimated Plasma Volume in Heart Failure. JACC Heart Fail 3:886–893
pubmed: 26541787
doi: 10.1016/j.jchf.2015.06.014
RM. H. Plasmapheresis. In: I. D. JT, B. PG and I. TS, eds (2001). Handbook of dialysis, 3rd ed Philadelphia: Lippincott. Williams and Wilkins 236
Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, Clemenza F, Tognoni G, Anand IS, Cohn JN, Anker SD, Tavazzi L, Latini R, on the behalf of G-H and Val-He FTI, (2015) Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur J Heart Fail 17(4):424–433
Martens P, Nijst P, Dupont M, Mullens W (2019) The optimal plasma volume status in heart failure in relation to clinical outcome. J Cardiac Failure 25(4):240–248
doi: 10.1016/j.cardfail.2018.11.019
Dworkin HJ, Premo M, Dees S (2007) Comparison of red cell and whole blood volume as performed using both chromium-51-tagged red cells and iodine-125-tagged albumin and using I-131-tagged albumin and extrapolated red cell volume. Am J Med Sci 334:37–40
pubmed: 17630590
doi: 10.1097/MAJ.0b013e3180986276
International Committee for Standardization in Haematology (1980) Recommended methods for measurement of red-cell and plasma volume: international committee for standardization in haematology. J Nuclear Med Off Publ Soc Nuclear Med 21:793–800
Molitoris BA, George AG, Murray PT, Meier D, Reilly ES, Barreto E, Sandoval RM, Rizk DV, Shaw AD, Peacock WF (2019) A novel fluorescent clinical method to rapidly quantify plasma volume. Cardiorenal Med 9:168–179
pubmed: 30844821
doi: 10.1159/000496480
Ling HZ, Flint J, Damgaard M, Bonfils PK, Cheng AS, Aggarwal S, Velmurugan S, Mendonca M, Rashid M, Kang S, Papalia F, Weissert S, Coats CJ, Thomas M, Kuskowski M, Cohn JN, Woldman S, Anand IS, Okonko DO (2015) Calculated plasma volume status and prognosis in chronic heart failure. Eur J Heart Fail 17:35–43
pubmed: 25469484
doi: 10.1002/ejhf.193
pmcid: 25469484
Fudim M, Miller WL (2018) Calculated estimates of plasma volume in patients with chronic heart failure-comparison with measured volumes. J Cardiac Failure 24(9):553–560
doi: 10.1016/j.cardfail.2018.07.462
Dekkers CCJ, Sjostrom CD, Greasley PJ, Cain V, Boulton DW, Heerspink HJL (2019) Effects of the sodium-glucose co-transporter-2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes. Diabet Obesity Metab 21(12):2667–2673
doi: 10.1111/dom.13855
Yoshihisa A, Abe S, Sato Y, Watanabe S, Yokokawa T, Miura S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Saitoh SI, Takeishi Y (2018) Plasma volume status predicts prognosis in patients with acute heart failure syndromes. Eur Heart J Acute Cardiovasc Care 7(4):330–338
pubmed: 28139135
doi: 10.1177/2048872617690889
pmcid: 28139135
Kataoka H (2017) Vascular expansion during worsening of heart failure: Effects on clinical features and its determinants. Int J Cardiol 230:556–561
pubmed: 28062134
doi: 10.1016/j.ijcard.2016.12.059
pmcid: 28062134
Grodin JL, Philips S, Mullens W, Nijst P, Martens P, Fang JC, Drazner MH, Tang WHW, Pandey A (2019) Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT. Eur J Heart Fail 21(5):634–642
pubmed: 30714658
doi: 10.1002/ejhf.1407
pmcid: 30714658
Kobayashi M, Huttin O, Donal E, Duarte K, Hubert A, Le Breton H, Galli E, Fournet M, Mabo P, Schnell F, Leclercq C, Rossignol P, Girerd N (2020) Association of estimated plasma volume status with hemodynamic and echocardiographic parameters. Clin Res Cardiol 109(8):1060–1069
pubmed: 32006155
doi: 10.1007/s00392-020-01599-9
pmcid: 32006155
Almufleh A, Desai AS, Fay R, Ferreira JP, Buckley LF, Mehra MR, Rossignol P, Zannad F (2020) Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients. Eur J Heart Fail 22(10):1907–1911
pubmed: 32353199
doi: 10.1002/ejhf.1848
Hayasaka K, Matsue Y, Kitai T, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Mizukami A, Yoshioka K, Kuroda S, Kagiyama N, Yamaguchi T and Sasano T (2020) Tricuspid regurgitation pressure gradient identifies prognostically relevant worsening renal function in acute heart failure. Eur Heart J Cardiovasc Imag
Rossignol P, Menard J, Fay R, Gustafsson F, Pitt B, Zannad F (2011) Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. J Am Coll Cardiol 58:1958–1966
pubmed: 22032706
doi: 10.1016/j.jacc.2011.04.049
Hamilton RW, Buckalew VM Jr (1984) Sodium, water, and congestive heart failure. Ann Intern Med 100:902–904
pubmed: 6372567
doi: 10.7326/0003-4819-100-6-902
Ghali JK, Tam SW (2010) The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists. J Card Fail 16:419–431
pubmed: 20447579
doi: 10.1016/j.cardfail.2009.12.021
Miller WL, Mullan BP (2016) Volume overload profiles in patients with preserved and reduced ejection fraction chronic heart failure: are there differences? A pilot study. JACC Heart Fail 4:453–459
pubmed: 26970830
doi: 10.1016/j.jchf.2016.01.005
Takei M, Kohsaka S, Shiraishi Y, Goda A, Izumi Y, Yagawa M, Mizuno A, Sawano M, Inohara T, Kohno T, Fukuda K, Yoshikawa T, West Tokyo Heart Failure Registry I (2015) Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction. Circulat Heart Failure 8:527–532
doi: 10.1161/CIRCHEARTFAILURE.114.001734
Kobayashi M, Rossignol P, Ferreira JP, Aragao I, Paku Y, Iwasaki Y, Watanabe M, Fudim M, Duarte K, Zannad F, Girerd N (2019) Prognostic value of estimated plasma volume in acute heart failure in three cohort studies. Clin Res Cardiol 108(5):549–561
pubmed: 30341579
doi: 10.1007/s00392-018-1385-1
Kobayashi M, Girerd N, Duarte K, Preud'homme G, Pitt B, Rossignol P (2020) Prognostic Impact of Plasma Volume Estimated from Hemoglobin and Hematocrit in Heart Failure with Preserved Ejection Fraction. Clin Res Cardiol. 109(11):1392–1401
pubmed: 32253507
doi: 10.1007/s00392-020-01639-4
Ergatoudes C, Schaufelberger M, Andersson B, Pivodic A, Dahlström U, Fu M (2019) Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry. Clin Res Cardiol 108:1025–1033
pubmed: 30788622
pmcid: 6694087
doi: 10.1007/s00392-019-01430-0
Streng KW, Nauta JF, Hillege HL, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Zannad F, Damman K, van der Meer P, Voors AA (2018) Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. Int J Cardiol 271:132–139
pubmed: 30482453
doi: 10.1016/j.ijcard.2018.04.001
Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, Clemenza F, Tognoni G, Anand IS, Cohn JN, Anker SD, Tavazzi L, Latini R, Gissi HF, Val-He FTI (2015) Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur J Heart Fail 17:424–433
pubmed: 25704364
doi: 10.1002/ejhf.240
Huang CY, Lin TT, Wu YF, Chiang FT, Wu CK (2019) Long-term prognostic value of estimated plasma volume in heart failure with preserved ejection fraction. Sci Rep 9:14369
pubmed: 31591412
pmcid: 6779908
doi: 10.1038/s41598-019-50427-2
Balderston JR, Shah KB, Paciulli SC, Gertz ZM (2018) Usefulness of estimated plasma volume at postdischarge follow-up to predict recurrent events in patients with heart failure. Am J Cardiol 122:1191–1194
pubmed: 30241666
doi: 10.1016/j.amjcard.2018.06.057
Hudson SR, Chan D, Ng LL (2016) Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study. J R Soc Med 109:337–346
pubmed: 27609799
pmcid: 5017520
doi: 10.1177/0141076816661316
Bilchick KC, Chishinga N, Parker AM, Zhuo DX, Rosner MH, Smith LA, Mwansa H, Blackwell JN, McCullough PA, Mazimba S (2017) Plasma volume and renal function predict six-month survival after hospitalization for acute decompensated heart failure. Cardiorenal Med 8:61–70
pubmed: 29344027
pmcid: 5757574
doi: 10.1159/000481149
Kobayashi M, Bercker M, Huttin O, Pierre S, Sadoul N, Bozec E, Chouihed T, Ferreira JP, Zannad F, Rossignol P, Girerd N (2020) Chest X-ray quantification of admission lung congestion as a prognostic factor in patients admitted for worsening heart failure from the ICALOR cohort study. Int J Cardiol 299:192–198
pubmed: 31281047
doi: 10.1016/j.ijcard.2019.06.062
Fudim M, Lerman JB, Page C, Alhanti B, Califf RM, Ezekowitz JA, Girerd N, Grodin JL, Miller WL, Pandey A, Rossignol P, Starling RC, Tang WHW, Zannad F, Hernandez AF, O'Connor CM and Mentz RJ (2020) Plasma volume status and its association with in-hospital and post-discharge outcomes in decompensated heart failure. J Card Fail
Maznyczka AM, Barakat MF, Ussen B, Kaura A, Abu-Own H, Jouhra F, Jaumdally H, Amin-Youssef G, Nicou N, Baghai M, Deshpande R, Wendler O, Kolvekar S, Okonko DO (2019) Calculated plasma volume status and outcomes in patients undergoing coronary bypass graft surgery. Heart 105:1020–1026
pubmed: 30826773
doi: 10.1136/heartjnl-2018-314246
Adlbrecht C, Piringer F, Resar J, Watzal V, Andreas M, Strouhal A, Hasan W, Geisler D, Weiss G, Grabenwöger M, Delle-Karth G, Mach M (2020) The impact of subclinical congestion on the outcome of patients undergoing transcatheter aortic valve implantation. Eur J Clin Invest 50:e13251
pmcid: 7507141
doi: 10.1111/eci.13251
pubmed: 7507141
Schaefer AK, Poschner T, Andreas M, Kocher A, Laufer G, Wiedemann D, Mach M (2020) Impact of subclinical congestion on outcome of patients undergoing mitral valve surgery. Biomedicines 8(9):363
pmcid: 7555884
doi: 10.3390/biomedicines8090363
pubmed: 7555884
Chouihed T, Rossignol P, Bassand A, Duarte K, Kobayashi M, Jaeger D, Sadoune S, Buessler A, Nace L, Giacomin G, Hutter T, Barbe F, Salignac S, Jay N, Zannad F, Girerd N (2019) Diagnostic and prognostic value of plasma volume status at emergency department admission in dyspneic patients: results from the PARADISE cohort. Clin Res Cardiol 108(5):563–573
pubmed: 30370469
doi: 10.1007/s00392-018-1388-y
Testani JM, Brisco MA, Chen J, McCauley BD, Parikh CR, Tang WH (2013) Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol 62:516–524
pubmed: 23747773
pmcid: 3892152
doi: 10.1016/j.jacc.2013.05.027
Parrinello G, Greene SJ, Torres D, Alderman M, Bonventre JV, Di Pasquale P, Gargani L, Nohria A, Fonarow GC, Vaduganathan M, Butler J, Paterna S, Stevenson LW, Gheorghiade M (2015) Water and sodium in heart failure: a spotlight on congestion. Heart Fail Rev 20:13–24
pubmed: 24942806
pmcid: 4405162
doi: 10.1007/s10741-014-9438-7
Davila C, Reyentovich A, Katz SD (2011) Clinical correlates of hemoconcentration during hospitalization for acute decompensated heart failure. J Card Fail 17:1018–1022
pubmed: 22123365
doi: 10.1016/j.cardfail.2011.08.004
Darawsha W, Chirmicci S, Solomonica A, Wattad M, Kaplan M, Makhoul BF, Abassi ZA, Azzam ZS, Aronson D (2016) Discordance between hemoconcentration and clinical assessment of decongestion in acute heart failure. J Card Fail 22:680–688
pubmed: 27079674
doi: 10.1016/j.cardfail.2016.04.005
Rao VS, Ahmad T, Brisco-Bacik MA, Bonventre JV, Wilson FP, Siew ED, Felker GM, Anstrom KK, Mahoney DD, Bart BA, Tang WHW, Velazquez EJ, Testani JM (2019) Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circ Heart Fail 12:e005552
pubmed: 31163974
pmcid: 6585463
doi: 10.1161/CIRCHEARTFAILURE.118.005552
Ferreira JP, Chouihed T, Nazeyrollas P, Levy B, Seronde MF, Bilbault P, Braun F, Roul G, Kenizou D, Zannad N, Girerd N, Rossignol P (2018) Practical management of concomitant acute heart failure and worsening renal function in the emergency department. Eur J Emerg Med Off J Eur Soc Emerg Med 25:229–236
doi: 10.1097/MEJ.0000000000000505
Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei CL (2012) Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 5:54–62
pubmed: 22167320
doi: 10.1161/CIRCHEARTFAILURE.111.963413
Damman K, Tang WH, Testani JM, McMurray JJ (2014) Terminology and definition of changes renal function in heart failure. Eur Heart J 35:3413–3416
pubmed: 25157110
pmcid: 4375406
doi: 10.1093/eurheartj/ehu320
Zannad F, Rossignol P (2018) Cardiorenal syndrome revisited. Circulation 138:929–944
pubmed: 30354446
doi: 10.1161/CIRCULATIONAHA.117.028814
Davison BA, Metra M, Cotter G, Massie BM, Cleland JGF, Dittrich HC, Edwards C, Filippatos G, Givertz MM, Greenberg B, Ponikowski P, Voors AA, O’Connor CM, Teerlink JR (2015) Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies. JACC Heart Fail 3:395–403
pubmed: 25951761
doi: 10.1016/j.jchf.2015.01.007
Davidov M, Kakaviatos N, Finnerty FA Jr (1967) Intravenous administration of furosemide in heart failure. JAMA 200:824–829
pubmed: 6071618
doi: 10.1001/jama.1967.03120230076009
Guazzi MD, Agostoni P, Perego B, Lauri G, Salvioni A, Giraldi F, Matturri M, Guazzi M, Marenzi G (1994) Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. British heart journal 72:534–539
pubmed: 7857735
pmcid: 1025638
doi: 10.1136/hrt.72.6.534
Boyle A, Sobotka PA (2006) Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate. J Card Fail 12:247–249
pubmed: 16679255
doi: 10.1016/j.cardfail.2006.01.011
Packer M, Kitzman DW (2018) Obesity-related heart failure with a preserved ejection fraction: the mechanistic rationale for combining inhibitors of aldosterone, neprilysin, and sodium-glucose cotransporter-2. JACC Heart Failure 6:633–639
pubmed: 29525327
doi: 10.1016/j.jchf.2018.01.009
Nakagawa H, Oberwinkler H, Nikolaev VO, Gaßner B, Umbenhauer S, Wagner H, Saito Y, Baba HA, Frantz S, Kuhn M (2014) Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation. Circ Heart Failure 7:814–821
pubmed: 25027872
doi: 10.1161/CIRCHEARTFAILURE.113.000885
pmcid: 25027872
McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381(21):1995–2008
pubmed: 31535829
doi: 10.1056/NEJMoa1911303
pmcid: 31535829
Rossignol P, Hernandez AF, Solomon SD, Zannad F (2019) Heart failure drug treatment. Lancet 393:1034–1044
pubmed: 30860029
doi: 10.1016/S0140-6736(18)31808-7
pmcid: 30860029
Lambers Heerspink HJ, de Zeeuw D, Wie L, Leslie B, List J (2013) Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes. Diabetes Obes Metab 15:853–862
pubmed: 23668478
doi: 10.1111/dom.12127
pmcid: 23668478
McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Bělohlávek J, Böhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukát A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O’Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjöstrand M, Langkilde AM (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995–2008
pubmed: 31535829
doi: 10.1056/NEJMoa1911303
pmcid: 31535829
Sano M, Goto S (2019) Possible mechanism of hematocrit elevation by sodium glucose cotransporter 2 inhibitors and associated beneficial renal and cardiovascular effects. Circulation 139:1985–1987
pubmed: 31009585
doi: 10.1161/CIRCULATIONAHA.118.038881
pmcid: 31009585
Heerspink HJL, Kosiborod M, Inzucchi SE, Cherney DZI (2018) Renoprotective effects of sodium-glucose cotransporter-2 inhibitors. Kidney Int 94:26–39
pubmed: 29735306
doi: 10.1016/j.kint.2017.12.027
pmcid: 29735306
Tang WHW, Telukuntla KS, Mayuga KA (2018) Can Blood Volume Analysis-Guided Acute Heart Failure Therapy Improve Clinical Outcomes? JACC Heart Fail 6:949–950
pubmed: 30316940
doi: 10.1016/j.jchf.2018.08.003
Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377:658–666
pubmed: 21315441
doi: 10.1016/S0140-6736(11)60101-3
Vaduganathan M, Greene SJ, Fonarow GC, Voors AA, Butler J, Gheorghiade M (2014) Hemoconcentration-guided diuresis in heart failure. Am J Med 127:1154–1159
pubmed: 24937157
doi: 10.1016/j.amjmed.2014.06.009
Rossignol P, Fay R, Girerd N, Zannad F (2020) Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post-discharge. ESC Heart Failure 7:1257–1263
pubmed: 32274878
pmcid: 7261583
doi: 10.1002/ehf2.12642
Okonko DO, Jouhra F, Abu-Own H, Filippatos G, Colet JC, Suki C, Mori C, Ponikowski P, Anker SD (2019) Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR-HF substudy. ESC Heart Fail 6:621–628
pubmed: 31148411
pmcid: 6676445
doi: 10.1002/ehf2.12462
Massari F, Scicchitano P, Iacoviello M, Passantino A, Guida P, Sanasi M, Piscopo A, Romito R, Valle R, Caldarola P, Ciccone MM (2019) Multiparametric approach to congestion for predicting long-term survival in heart failure. J Cardiol 75(1):47–52
pubmed: 31326239
doi: 10.1016/j.jjcc.2019.05.017
Tamaki S, Yamada T, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kawai T, Seo M, Abe M, Nakamura J, Yamamoto K, Kayama K, Kawahira M, Tanabe K, Ueda K, Kimura T, Sakamoto D, Fukunami M (2019) Prognostic value of calculated plasma volume status in patients admitted for acute decompensated heart failure: a prospective comparative study with other indices of plasma volume. Circ Rep 1:361–371
pubmed: 33693164
pmcid: 7892481
doi: 10.1253/circrep.CR-19-0039